0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cannabis Use Disorder Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-8R13490
Home | Market Reports | Health| Pharmacy
Global Cannabis Use Disorder Treatment Market Research Report 2023
BUY CHAPTERS

Cannabis Use Disorder Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8R13490
Report
September 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cannabis Use Disorder Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cannabis Use Disorder Treatment - Market

Cannabis Use Disorder Treatment - Market

The global market for Cannabis Use Disorder Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cannabis Use Disorder Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cannabis Use Disorder Treatment by region & country, by Type, and by Application.
The Cannabis Use Disorder Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Use Disorder Treatment.
Market Segmentation

Scope of Cannabis Use Disorder Treatment - Market Report

Report Metric Details
Report Name Cannabis Use Disorder Treatment - Market
CAGR 5%
Segment by Type:
  • Tobacco/Nicotine and Vaping
  • Alcohol
  • Marijuana
  • Synthetic Cannabinoids
  • Others
Segment by Application
  • Hospitals and Clinics
  • Rehabilitation Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, Orexo AB, Purdue Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Cannabis Use Disorder Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Cannabis Use Disorder Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Cannabis Use Disorder Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Cannabis Use Disorder Treatment - Market report?

Ans: The main players in the Cannabis Use Disorder Treatment - Market are AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, Orexo AB, Purdue Pharma

What are the Application segmentation covered in the Cannabis Use Disorder Treatment - Market report?

Ans: The Applications covered in the Cannabis Use Disorder Treatment - Market report are Hospitals and Clinics, Rehabilitation Centers, Others

What are the Type segmentation covered in the Cannabis Use Disorder Treatment - Market report?

Ans: The Types covered in the Cannabis Use Disorder Treatment - Market report are Tobacco/Nicotine and Vaping, Alcohol, Marijuana, Synthetic Cannabinoids, Others

1 Market Overview
1.1 Cannabis Use Disorder Treatment Product Introduction
1.2 Global Cannabis Use Disorder Treatment Market Size Forecast
1.3 Cannabis Use Disorder Treatment Market Trends & Drivers
1.3.1 Cannabis Use Disorder Treatment Industry Trends
1.3.2 Cannabis Use Disorder Treatment Market Drivers & Opportunity
1.3.3 Cannabis Use Disorder Treatment Market Challenges
1.3.4 Cannabis Use Disorder Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cannabis Use Disorder Treatment Players Revenue Ranking (2023)
2.2 Global Cannabis Use Disorder Treatment Revenue by Company (2019-2024)
2.3 Key Companies Cannabis Use Disorder Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cannabis Use Disorder Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Cannabis Use Disorder Treatment
2.6 Cannabis Use Disorder Treatment Market Competitive Analysis
2.6.1 Cannabis Use Disorder Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cannabis Use Disorder Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tobacco/Nicotine and Vaping
3.1.2 Alcohol
3.1.3 Marijuana
3.1.4 Synthetic Cannabinoids
3.1.5 Others
3.2 Global Cannabis Use Disorder Treatment Sales Value by Type
3.2.1 Global Cannabis Use Disorder Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cannabis Use Disorder Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Cannabis Use Disorder Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Rehabilitation Centers
4.1.3 Others
4.2 Global Cannabis Use Disorder Treatment Sales Value by Application
4.2.1 Global Cannabis Use Disorder Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cannabis Use Disorder Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Cannabis Use Disorder Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cannabis Use Disorder Treatment Sales Value by Region
5.1.1 Global Cannabis Use Disorder Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cannabis Use Disorder Treatment Sales Value by Region (2019-2024)
5.1.3 Global Cannabis Use Disorder Treatment Sales Value by Region (2025-2030)
5.1.4 Global Cannabis Use Disorder Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cannabis Use Disorder Treatment Sales Value, 2019-2030
5.2.2 North America Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cannabis Use Disorder Treatment Sales Value, 2019-2030
5.3.2 Europe Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cannabis Use Disorder Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cannabis Use Disorder Treatment Sales Value, 2019-2030
5.5.2 South America Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cannabis Use Disorder Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cannabis Use Disorder Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cannabis Use Disorder Treatment Sales Value
6.3 United States
6.3.1 United States Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.3.2 United States Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.4.2 Europe Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.5.2 China Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.6.2 Japan Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.7.2 South Korea Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cannabis Use Disorder Treatment Sales Value, 2019-2030
6.9.2 India Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cannabis Use Disorder Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Profile
7.1.2 AbbVie Main Business
7.1.3 AbbVie Cannabis Use Disorder Treatment Products, Services and Solutions
7.1.4 AbbVie Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 AbbVie Recent Developments
7.2 Alkermes
7.2.1 Alkermes Profile
7.2.2 Alkermes Main Business
7.2.3 Alkermes Cannabis Use Disorder Treatment Products, Services and Solutions
7.2.4 Alkermes Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Alkermes Recent Developments
7.3 BioCorRx
7.3.1 BioCorRx Profile
7.3.2 BioCorRx Main Business
7.3.3 BioCorRx Cannabis Use Disorder Treatment Products, Services and Solutions
7.3.4 BioCorRx Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Cipla Limited Recent Developments
7.4 Cipla Limited
7.4.1 Cipla Limited Profile
7.4.2 Cipla Limited Main Business
7.4.3 Cipla Limited Cannabis Use Disorder Treatment Products, Services and Solutions
7.4.4 Cipla Limited Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Cipla Limited Recent Developments
7.5 Dr. Reddy’s Laboratories
7.5.1 Dr. Reddy’s Laboratories Profile
7.5.2 Dr. Reddy’s Laboratories Main Business
7.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Products, Services and Solutions
7.5.4 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Dr. Reddy’s Laboratories Recent Developments
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Glenmark Pharmaceuticals Limited Profile
7.6.2 Glenmark Pharmaceuticals Limited Main Business
7.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Products, Services and Solutions
7.6.4 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Glenmark Pharmaceuticals Limited Recent Developments
7.7 Intas Pharmaceuticals Limited
7.7.1 Intas Pharmaceuticals Limited Profile
7.7.2 Intas Pharmaceuticals Limited Main Business
7.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Products, Services and Solutions
7.7.4 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Intas Pharmaceuticals Limited Recent Developments
7.8 Indivior
7.8.1 Indivior Profile
7.8.2 Indivior Main Business
7.8.3 Indivior Cannabis Use Disorder Treatment Products, Services and Solutions
7.8.4 Indivior Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Indivior Recent Developments
7.9 Mallinckrodt
7.9.1 Mallinckrodt Profile
7.9.2 Mallinckrodt Main Business
7.9.3 Mallinckrodt Cannabis Use Disorder Treatment Products, Services and Solutions
7.9.4 Mallinckrodt Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Mallinckrodt Recent Developments
7.10 Noramco
7.10.1 Noramco Profile
7.10.2 Noramco Main Business
7.10.3 Noramco Cannabis Use Disorder Treatment Products, Services and Solutions
7.10.4 Noramco Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Noramco Recent Developments
7.11 Orexo AB
7.11.1 Orexo AB Profile
7.11.2 Orexo AB Main Business
7.11.3 Orexo AB Cannabis Use Disorder Treatment Products, Services and Solutions
7.11.4 Orexo AB Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Orexo AB Recent Developments
7.12 Purdue Pharma
7.12.1 Purdue Pharma Profile
7.12.2 Purdue Pharma Main Business
7.12.3 Purdue Pharma Cannabis Use Disorder Treatment Products, Services and Solutions
7.12.4 Purdue Pharma Cannabis Use Disorder Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Purdue Pharma Recent Developments
8 Industry Chain Analysis
8.1 Cannabis Use Disorder Treatment Industrial Chain
8.2 Cannabis Use Disorder Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cannabis Use Disorder Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Cannabis Use Disorder Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Cannabis Use Disorder Treatment Market Trends
    Table 2. Cannabis Use Disorder Treatment Market Drivers & Opportunity
    Table 3. Cannabis Use Disorder Treatment Market Challenges
    Table 4. Cannabis Use Disorder Treatment Market Restraints
    Table 5. Global Cannabis Use Disorder Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cannabis Use Disorder Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Cannabis Use Disorder Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Cannabis Use Disorder Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Cannabis Use Disorder Treatment
    Table 10. Global Cannabis Use Disorder Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Cannabis Use Disorder Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Cannabis Use Disorder Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Cannabis Use Disorder Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Cannabis Use Disorder Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Cannabis Use Disorder Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Cannabis Use Disorder Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Cannabis Use Disorder Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Cannabis Use Disorder Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Cannabis Use Disorder Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Cannabis Use Disorder Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Cannabis Use Disorder Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Cannabis Use Disorder Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Cannabis Use Disorder Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Cannabis Use Disorder Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Cannabis Use Disorder Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Cannabis Use Disorder Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Cannabis Use Disorder Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Cannabis Use Disorder Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. AbbVie Basic Information List
    Table 32. AbbVie Description and Business Overview
    Table 33. AbbVie Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of AbbVie (2019-2024)
    Table 35. AbbVie Recent Developments
    Table 36. Alkermes Basic Information List
    Table 37. Alkermes Description and Business Overview
    Table 38. Alkermes Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Alkermes (2019-2024)
    Table 40. Alkermes Recent Developments
    Table 41. BioCorRx Basic Information List
    Table 42. BioCorRx Description and Business Overview
    Table 43. BioCorRx Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of BioCorRx (2019-2024)
    Table 45. BioCorRx Recent Developments
    Table 46. Cipla Limited Basic Information List
    Table 47. Cipla Limited Description and Business Overview
    Table 48. Cipla Limited Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Cipla Limited (2019-2024)
    Table 50. Cipla Limited Recent Developments
    Table 51. Dr. Reddy’s Laboratories Basic Information List
    Table 52. Dr. Reddy’s Laboratories Description and Business Overview
    Table 53. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Dr. Reddy’s Laboratories (2019-2024)
    Table 55. Dr. Reddy’s Laboratories Recent Developments
    Table 56. Glenmark Pharmaceuticals Limited Basic Information List
    Table 57. Glenmark Pharmaceuticals Limited Description and Business Overview
    Table 58. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Glenmark Pharmaceuticals Limited (2019-2024)
    Table 60. Glenmark Pharmaceuticals Limited Recent Developments
    Table 61. Intas Pharmaceuticals Limited Basic Information List
    Table 62. Intas Pharmaceuticals Limited Description and Business Overview
    Table 63. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Intas Pharmaceuticals Limited (2019-2024)
    Table 65. Intas Pharmaceuticals Limited Recent Developments
    Table 66. Indivior Basic Information List
    Table 67. Indivior Description and Business Overview
    Table 68. Indivior Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Indivior (2019-2024)
    Table 70. Indivior Recent Developments
    Table 71. Mallinckrodt Basic Information List
    Table 72. Mallinckrodt Description and Business Overview
    Table 73. Mallinckrodt Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Mallinckrodt (2019-2024)
    Table 75. Mallinckrodt Recent Developments
    Table 76. Noramco Basic Information List
    Table 77. Noramco Description and Business Overview
    Table 78. Noramco Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Noramco (2019-2024)
    Table 80. Noramco Recent Developments
    Table 81. Orexo AB Basic Information List
    Table 82. Orexo AB Description and Business Overview
    Table 83. Orexo AB Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Orexo AB (2019-2024)
    Table 85. Orexo AB Recent Developments
    Table 86. Purdue Pharma Basic Information List
    Table 87. Purdue Pharma Description and Business Overview
    Table 88. Purdue Pharma Cannabis Use Disorder Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Cannabis Use Disorder Treatment Business of Purdue Pharma (2019-2024)
    Table 90. Purdue Pharma Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Cannabis Use Disorder Treatment Downstream Customers
    Table 94. Cannabis Use Disorder Treatment Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Cannabis Use Disorder Treatment Product Picture
    Figure 2. Global Cannabis Use Disorder Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cannabis Use Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Cannabis Use Disorder Treatment Report Years Considered
    Figure 5. Global Cannabis Use Disorder Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabis Use Disorder Treatment Revenue in 2023
    Figure 7. Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Tobacco/Nicotine and Vaping Picture
    Figure 9. Alcohol Picture
    Figure 10. Marijuana Picture
    Figure 11. Synthetic Cannabinoids Picture
    Figure 12. Others Picture
    Figure 13. Global Cannabis Use Disorder Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Cannabis Use Disorder Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Hospitals and Clinics
    Figure 16. Product Picture of Rehabilitation Centers
    Figure 17. Product Picture of Others
    Figure 18. Global Cannabis Use Disorder Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Cannabis Use Disorder Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Cannabis Use Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Cannabis Use Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Cannabis Use Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Cannabis Use Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Cannabis Use Disorder Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Cannabis Use Disorder Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Cannabis Use Disorder Treatment Sales Value (%), (2019-2030)
    Figure 31. United States Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Cannabis Use Disorder Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Cannabis Use Disorder Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Cannabis Use Disorder Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 52. Cannabis Use Disorder Treatment Industrial Chain
    Figure 53. Cannabis Use Disorder Treatment Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS